Education
About Us
Working with TipRanks
Follow Us
BeiGene Ltd (HK:6160)
:6160
Comparison Results
Innovent Biologics
HK$81.10
HK$140.68B
109.18
145.39%
5 Buy
0 Hold
0 Sell
Strong Buy
Wuxi Biologics (Cayman)
HK$37.00
HK$152.94B
33.19
100.87%
3 Buy
0 Hold
0 Sell
Strong Buy
WuXi AppTec Co., Ltd. Class H
HK$113.60
HK$314.39B
19.89
101.45%
4 Buy
0 Hold
0 Sell
Strong Buy
Hansoh Pharmaceutical Group Company Limited
HK$38.60
HK$233.73B
44.46
115.88%
3 Buy
0 Hold
0 Sell
Strong Buy
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H
HK$68.45
HK$432.07B
58.89
24.12%
2 Buy
0 Hold
0 Sell
Moderate Buy
Performance Comparison
HK:6160
BeiGene Ltd
206.60
71.60
53.04%
HK:1801
Innovent Biologics
81.10
48.35
147.63%
HK:2269
Wuxi Biologics (Cayman)
37.00
18.52
100.22%
HK:2359
WuXi AppTec Co., Ltd. Class H
111.20
57.07
105.43%
HK:3692
Hansoh Pharmaceutical Group Company Limited
38.60
21.00
119.32%
HK:1276
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H
68.45
14.75
27.47%